Status:
UNKNOWN
GMA and Peri in Moderate-late Preterms
Lead Sponsor:
University of Castilla-La Mancha
Conditions:
Preterm
Assessment
Eligibility:
All Genders
32-36 years
Brief Summary
To analyze the relationship between the early diagnosis of cerebral palsy with the risk factors of this pathology in moderate and late premature infants
Detailed Description
Analyze a sample of moderate and late premature infants using general movements and verify which of them would have an early diagnosis of cerebral palsy and relate it to their risk factors for this pa...
Eligibility Criteria
Inclusion
- Subjects who were born between the week 32 + 0 days and the week 36 + 6 days and who are admitted to the Hospital Nuestra Señora del Prado de Talavera de la Reina or the Hospital Virgen de la Salud de Toledo.
Exclusion
- Any type of pre and perinatal diagnostic neurological involvement.
- Any type of pathology associated with prematurity.
- Children who have prescribed any of the following medications (10):
- Barbiturates
- Antiepileptic
- Indomethacin
- Dexamethasone
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04073836
Start Date
January 1 2019
End Date
December 31 2021
Last Update
August 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Javier Merino Andrés
Toledo, Spain, 45006